LexDanaLexDanabeta
Inventor

Wesley Blackaby

Inventor
Saffron Walden, GB

Overview

30→
Patents
2001–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds4%
B21DWorking or processing of sheet metal or metal tubes, rods or profiles without essentially removing material1%
H05KPrinted circuits1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
10,155,259FSH receptor antagonists201810,117,860Aminoester derivatives201810,087,1763,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors20189,931,323Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use20189,809,582'Aminoester derivatives'20179,763,924'Aminoester derivatives'20179,636,336'Aminoester derivatives'20179,328,106'Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use'20169,199,980'Compounds'20159,127,007'FSH receptor antagonists'20159,044,463'FSH receptor antagonists'20159,012,644'Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity'20158,993,757'N-piperidin-4-yl derivatives'20158,853,193'Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions'20148,802,663'Pyrazole oxadiazole derivatives as S1P1 agonists'20148,754,079'Cycloalkyl containing thienopyrimidines for pharmaceutical compositions'20148,648,068'Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions'20148,486,953'Thienopyrimidines for pharmaceutical compositions'20138,202,856'Triazole oxadiazoles derivatives'20128,163,956'Inhibitors of GLYT1 transporters'20127,851,638'Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia'20107,825,135'Heteroaryl piperidine glycine transporter inhibitors'20107,655,644'Piperidine and azetidine derivatives as GlyT1 inhibitors'20107,626,056'Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia'20097,226,926'8-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptors'20077,030,128'Imidazo-pyrimidine derivatives as ligands for GABA receptors'20066,969,716'5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression'20056,730,676'Pyrazino-pyridazine derivatives as ligands for GABA receptors'20046,642,229'3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors'20036,333,336'Pyrazolo-pyridine derivatives as ligands for GABA receptors'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2018Patents assigned to MERCK SHARP & DOHME (15)· patent assignee history
2003–2010Based in Buckhurst Hill, GB· patent location history
2010Based in Harlow, GB· patent location history
2012–2015Patents assigned to BLACKABY WESLEY (7)· patent assignee history
2012–2018Based in Essex, GB· patent location history
2012Based in Epping, GB· patent location history
2013–2015Patents assigned to LINNEY IAN (5)· patent assignee history
2013–2014Patents assigned to AUSTEN MATTHIAS (4)· patent assignee history
2013–2018Based in Saffron Walden, GB· patent location history
2017–2018Patents assigned to CHIESI FARM SPA (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME152001–2018
BLACKABY WESLEYself72012–2015
CHIESI FARM SPA52017–2018
LINNEY IAN52013–2015
AUSTEN MATTHIAS42013–2014
Locations
LocationPatentsSpan
Saffron Walden, GB152013–2018
Buckhurst Hill, GB82003–2010
Essex, GB42012–2018
Epping, GB12012
Harlow, GB12010